Published in Mol Psychiatry on May 27, 2008
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol (2011) 2.87
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry (2013) 2.17
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15
Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 2.12
Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54
Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience (2009) 1.49
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry (2012) 1.41
Depression and immunity: a role for T cells? Brain Behav Immun (2009) 1.40
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology (2012) 1.28
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry (2012) 1.22
A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci (2012) 1.20
Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry (2012) 1.17
The concept of depression as a dysfunction of the immune system. Curr Immunol Rev (2010) 1.06
Inflammatory T helper 17 cells promote depression-like behavior in mice. Biol Psychiatry (2012) 1.05
Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive disorder. PLoS One (2014) 1.02
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry (2016) 1.01
Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol (2010) 0.97
Treating depression and depression-like behavior with physical activity: an immune perspective. Front Psychiatry (2013) 0.95
Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide. PLoS One (2012) 0.91
Pharmacogenomics of antidepressant treatment effects. Dialogues Clin Neurosci (2011) 0.91
Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy. PLoS One (2012) 0.88
Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Transl Psychiatry (2014) 0.86
Hippocampal gene expression in a rat model of depression after electroacupuncture at the Baihui and Yintang acupoints. Neural Regen Res (2014) 0.85
Inflammatory cytokine-associated depression. Brain Res (2014) 0.84
A tale of two comorbidities: Understanding the neurobiology of depression and pain. Indian J Psychiatry (2010) 0.84
Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol (Lausanne) (2013) 0.83
Association of PDE11A global haplotype with major depression and antidepressant drug response. Neuropsychiatr Dis Treat (2009) 0.83
The PHF21B gene is associated with major depression and modulates the stress response. Mol Psychiatry (2016) 0.82
Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women. Depress Anxiety (2013) 0.82
Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Med Genet (2008) 0.80
Mental quality of life is related to a cytokine genetic pathway. PLoS One (2012) 0.80
Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci (2015) 0.79
Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy. J Clin Cell Immunol (2014) 0.79
Genetic Contributions of Inflammation to Depression. Neuropsychopharmacology (2016) 0.79
Gene-environment interactions in geriatric depression. Psychiatr Clin North Am (2011) 0.79
A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction. Psychiatr Genet (2013) 0.79
Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics. J Neural Transm (Vienna) (2012) 0.78
Neuroimmunological function in parents of children suffering from cancer. J Neural Transm (Vienna) (2013) 0.78
An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes? J Chem Biol (2010) 0.78
Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia. Dis Markers (2013) 0.78
MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder. PLoS One (2012) 0.77
Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes. Neuropsychiatr Dis Treat (2015) 0.76
Can we clinically recognize a vascular depression? The role of personality in an expanded threshold model. Medicine (Baltimore) (2015) 0.76
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders. Curr Neuropharmacol (2016) 0.76
Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models. BMC Syst Biol (2010) 0.76
The fiery landscape of depression: A review of the inflammatory hypothesis. Pak J Med Sci (2013) 0.76
Contributions of the adaptive immune system to mood regulation: Mechanisms and pathways of neuroimmune interactions. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75
Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4(+)CD25(+) regulatory T cells. Neuropsychiatr Dis Treat (2016) 0.75
Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems. Transl Psychiatry (2017) 0.75
Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function. PLoS One (2016) 0.75
T2D and Depression Risk Gene Proteasome Modulator 9 is Linked to Insomnia. Sci Rep (2015) 0.75
Role of Sirtuins in Linking Metabolic Syndrome with Depression. Front Cell Neurosci (2016) 0.75
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Transl Psychiatry (2015) 0.75
Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat (2017) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 18.98
Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science (2002) 8.34
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature (2007) 7.07
Chemokines and disease. Nat Immunol (2001) 5.62
Dendritic cell regulation of TH1-TH2 development. Nat Immunol (2000) 5.13
What does Stat3 do? J Clin Invest (2002) 4.83
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet (2002) 4.29
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med (1987) 4.21
The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med (2000) 4.11
T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science (2005) 3.65
Depression and the course of coronary artery disease. Am J Psychiatry (1998) 3.17
Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry (2000) 2.96
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science (1984) 2.83
Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med (2001) 2.33
Research and treatment approaches to depression. Nat Rev Neurosci (2001) 2.24
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
The psychosocial burden of psoriasis. Am J Clin Dermatol (2005) 1.81
Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet (2003) 1.77
Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med (1991) 1.51
Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem (2003) 1.45
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry (1994) 1.45
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians (1999) 1.41
Viewing chemokines as a third major system of communication in the brain. AAPS J (2006) 1.39
Specific requirement for CD3epsilon in T cell development. Proc Natl Acad Sci U S A (1998) 1.37
Mental disorders among adults with asthma: results from the World Mental Health Survey. Gen Hosp Psychiatry (2007) 1.36
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry (2004) 1.36
Indicators of immune activation in major depression. Psychiatry Res (1996) 1.30
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci U S A (2006) 1.23
The immunoregulatory effects of antidepressants. Hum Psychopharmacol (2001) 1.18
From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov (2004) 1.18
Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet (2005) 1.14
Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med (1984) 1.12
Cortisol production in depressive illness. A clinical and biochemical clarification. Arch Gen Psychiatry (1970) 1.11
Th2 cytokine response in Major Depressive Disorder patients before treatment. J Neuroimmunol (2006) 1.04
STAT3 mutation in the original patient with Job's syndrome. N Engl J Med (2007) 0.99
Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res (2005) 0.98
Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet (1993) 0.96
Molecular mechanisms regulating the retrograde axonal transport of neurotrophins. Brain Res Brain Res Rev (2000) 0.95
PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes. J Cell Physiol (2007) 0.95
The genetics of proteasomes and antigen processing. Annu Rev Genet (1995) 0.94
Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. Proc Am Thorac Soc (2004) 0.92
cDNA cloning and characterization of a human proteasomal modulator subunit, p27 (PSMD9). Genomics (1998) 0.92
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J Neurol Sci (2002) 0.91
Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation. Eur J Immunol (1991) 0.90
Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand (1996) 0.86
[Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV -- options book]. Psychiatr Pol (1994) 0.86
St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry (2004) 0.85
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet (2004) 0.83
Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicol Sci (2006) 0.80
Using genetic variation to study immunomodulation. Curr Opin Pharmacol (2002) 0.79
The Nobel chronicles. 1927: Julius Wagner-Jauregg (1857-1940). Lancet (1998) 0.77
Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development. Neuroscience (2002) 0.77
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69
Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab (1999) 3.26
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry (2004) 2.98
MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev (2001) 2.48
Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab (1999) 2.40
Leukocyte relaxation properties. Biophys J (1988) 2.27
Research and treatment approaches to depression. Nat Rev Neurosci (2001) 2.24
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Defective antigen processing in GILT-free mice. Science (2001) 2.16
Molecular psychiatry: does a new field need to examine strategy? Mol Psychiatry (1997) 2.07
Premedication with intravenous dexmedetomidine-midazolam suppresses fentanyl-induced cough. Ir J Med Sci (2012) 2.06
Cardiovascular and neuroendocrine adjustment to public speaking and mental arithmetic stressors. Psychophysiology (1997) 1.81
Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab (1998) 1.80
MicroRNA and drug resistance. Cancer Gene Ther (2010) 1.80
Influence of cell deformation on leukocyte rolling adhesion in shear flow. J Biomech Eng (1999) 1.61
Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry (2006) 1.61
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
A feedback-controlled ensemble model of the stress-responsive hypothalamo-pituitary-adrenal axis. Proc Natl Acad Sci U S A (2001) 1.55
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
Second primary cancer after in situ and invasive cervical cancer. Epidemiology (2000) 1.53
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med (1996) 1.46
Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer (2001) 1.44
Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev (2000) 1.42
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J (2012) 1.40
c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol Cell Biol (2000) 1.38
Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab (2001) 1.38
Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci U S A (2000) 1.34
The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology (1999) 1.32
Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci (2007) 1.32
Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci U S A (1997) 1.30
In vitro side-view imaging technique and analysis of human T-leukemic cell adhesion to ICAM-1 in shear flow. Microvasc Res (1998) 1.26
Ten years of leptin replacement therapy. Obes Rev (2011) 1.25
Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun (1997) 1.25
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry (1999) 1.20
Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.18
Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry (2012) 1.17
Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol (2000) 1.17
Currents connecting communities: nearshore community similarity and ocean circulation. Ecology (2011) 1.16
Application of the dual-micropipet technique to the measurement of tumor cell locomotion. Exp Cell Res (1999) 1.15
JNK1 is required for T cell-mediated immunity against Leishmania major infection. J Immunol (2000) 1.15
Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry (2001) 1.09
Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin. J Biol Chem (2000) 1.08
The effects of stress on brain and adrenal stem cells. Mol Psychiatry (2016) 1.08
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry (2002) 1.08
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry (2009) 1.08
The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract (2010) 1.08
MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes. Domest Anim Endocrinol (2009) 1.04
A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet (2000) 1.04
Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. Mol Psychiatry (1996) 1.03
Familial risks in cervical cancer: is there a hereditary component? Int J Cancer (1999) 1.02
Abeta40 promotes neuronal cell fate in neural progenitor cells. Cell Death Differ (2008) 1.02
Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol (2001) 1.01
Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett (2002) 1.01
[Ca2+]i as a potential downregulator of alpha2beta1-integrin-mediated A2058 tumor cell migration to type IV collagen. Am J Physiol Cell Physiol (2001) 1.00
Development of a side-view chamber for studying cell-surface adhesion under flow conditions. Ann Biomed Eng (1997) 0.99
Localization of urocortin messenger RNA in rat brain and pituitary. Mol Psychiatry (1996) 0.99
Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab (2001) 0.99
Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism (1999) 0.97
Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci (1995) 0.97
Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. J Immunol (1999) 0.97
The nitric oxide hypothesis of aging. Exp Gerontol (1999) 0.97
Familial relationships in thyroid cancer by histo-pathological type. Int J Cancer (2000) 0.97
Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology (1994) 0.97
Passive deformations and active motions of leukocytes. J Biomech Eng (1990) 0.96
Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers: etiological links? Int J Cancer (2001) 0.96
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull (1993) 0.96
Long-term body weight outcomes of antidepressant-environment interactions. Mol Psychiatry (2010) 0.96
Chromaffin cells: the peripheral brain. Mol Psychiatry (2012) 0.94
Second primary breast cancer in men. Breast Cancer Res Treat (2001) 0.93
Brain-derived neurotrophic factor (BDNF) in stress and affective disorders. Mol Psychiatry (2002) 0.92
Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma. Clin Exp Immunol (2011) 0.92
Molecular basis of T-cell differentiation. Cold Spring Harb Symp Quant Biol (1999) 0.91
Leptin. Int J Biochem Cell Biol (1998) 0.91
Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment. Horm Metab Res (2008) 0.90
Acute tryptophan depletion: a method of studying antidepressant action. J Clin Psychiatry (1992) 0.90
Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull (1991) 0.90
Development of a new animal model of liver cirrhosis in swine. Eur Surg Res (2008) 0.89
NMR structure of the complex between the zinc finger protein NCp10 of Moloney murine leukemia virus and the single-stranded pentanucleotide d(ACGCC): comparison with HIV-NCp7 complexes. Biochemistry (1999) 0.89
Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci (1999) 0.89
Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays. Transpl Infect Dis (2013) 0.88
Cancer in husbands of cervical cancer patients. Epidemiology (2000) 0.88
Pharmacogenomics of antidepressants: what is next? Mol Psychiatry (2010) 0.88
Primary cancers following squamous cell carcinoma of the skin suggest involvement of Epstein-Barr virus. Epidemiology (2000) 0.88
IL-1 beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas. Neuroreport (1996) 0.88
Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards. Pharmacogenomics J (2004) 0.87
A novel conceptual framework for psychiatry: vertically and horizontally integrated approaches to redundancy and pleiotropism that co-exist with a classification of symptom clusters based on DSM-5. Mol Psychiatry (2013) 0.86
A contingent aftereffect in the auditory system. Nat Neurosci (1999) 0.86
Cancers in the first-degree relatives of children with brain tumours. Br J Cancer (2000) 0.86
St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry (2004) 0.85
Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems. Mol Psychiatry (2012) 0.85
Localization of interleukin 1 type I receptor mRNA in rat brain. Neuroimmunomodulation (1996) 0.85
Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochem Biophys Res Commun (1995) 0.85
Direct lymphatic drainage from the esophagus into the thoracic duct. Surg Radiol Anat (1994) 0.85